All content on this website — including descriptions of modalities, research summaries, physiological explanations, and protocol recommendations — is provided for educational and informational purposes only. Nothing on this site constitutes, or should be interpreted as, medical advice, clinical guidance, diagnosis, or treatment of any health condition or disease. SONA Wellness does not practice medicine.
Where peer-reviewed studies and clinical research are referenced on this site, those citations are provided to illustrate the existing scientific literature in relevant areas. Citation of a study does not imply that SONA Wellness endorses or adopts its conclusions, nor does it constitute a claim of efficacy for any specific individual. Research findings are population-level observations and may not apply to any particular person. Many cited studies are preliminary or have limitations acknowledged by their own authors. The body of evidence for some modalities remains developing and is not universally accepted in mainstream medicine.
The U.S. Food and Drug Administration (FDA) classifies ozone as a toxic gas and has not approved ozone therapy for the treatment, cure, mitigation, or prevention of any disease or medical condition. Ozone therapy — including EBOO — is offered at SONA Wellness as a supportive wellness service, not as a medical treatment. References to published research on EBOO or ozone therapy do not constitute or imply FDA approval of these services.
Wellness outcomes vary significantly between individuals. No specific results are guaranteed. Factors including individual health status, existing conditions, medications, lifestyle, and consistency of protocol participation will influence what any person experiences. Testimonials or case studies, if shown, reflect individual experiences and are not representative of typical outcomes.
Before beginning any new wellness protocol at SONA — particularly if you have a diagnosed medical condition, are taking prescription medications, are pregnant or nursing, or are immunocompromised — you should consult with a licensed medical professional. SONA Wellness services are not a substitute for appropriate medical care. If you are experiencing a medical emergency, contact emergency services immediately.
Each modality offered at SONA Wellness has known contraindications. These will be reviewed during your intake assessment. It is your responsibility to disclose all relevant health information to our team prior to any session. SONA Wellness reserves the right to decline services where contraindications are identified.
Engaging with this website, booking a session, or receiving services at SONA Wellness does not create a medical practitioner-patient relationship. Our wellness specialists are trained in the operation of wellness modalities; they are not licensed medical practitioners and do not provide medical diagnoses or prescriptions.
Five clinical modalities — each addressing your body at the cellular level. Not softer. Stronger.
SONA was built for those who refuse to settle — for what they're told their body can handle, for results that stop at the surface, for wellness that treats the symptom while the cause remains. Every protocol here runs deeper.
Every modality targets the body at its most fundamental level — mitochondria, blood, gut, lymph. We address the root, not the symptom. Symptom masking is not something we do here.
Each protocol is grounded in peer-reviewed clinical research. Our equipment is medical-grade. We do not offer unproven treatments — every modality has a measurable, documented physiological mechanism behind it.
Trifecta Light Beds. Closed-system colonics. Dual-tier EBOO. If there is a better version of a machine, SONA has it. There is no consumer-grade equipment in this studio. This is not negotiable.
660–850nm wavelengths penetrate to the mitochondrial level, driving ATP synthesis, reducing systemic inflammation, and accelerating cellular repair across the full body simultaneously.
Sessions run 20–40 min in the Trifecta Light Bed. Wear minimal clothing for maximum skin exposure. Most clients notice improved energy and skin quality within 3–5 sessions.
A closed-system session that eliminates accumulated waste, rebalances gut microbiome, and restores the body's primary detoxification pathway with complete clinical privacy.
Sessions are 45–60 min in a private room using a closed-system device — no odor, complete discretion. Light eating only before the session. Hydrate well afterward.
Blood is drawn, ozonated with medical-grade O₃, UV-irradiated, and returned — supercharging immune response and restoring oxygen utilization at the blood level. Available in two tiers.
60–90 min sessions. Blood drawn, processed through ozone and UV irradiation, returned. Tier selection (Standard vs High Dosage) determined at intake assessment.
Far-infrared wavelengths penetrate 4–5cm below the skin surface, raising core body temperature to trigger deep detoxification and cardiovascular conditioning at depths no conventional sauna can reach.
30–45 min in a private infrared cabin at 110–145°F. Hydrate well beforehand. Most clients experience a profound, lasting calm post-session.
Pneumatic sequential compression drives lymphatic drainage, accelerates metabolite clearance, and stimulates deep blood flow — closing the recovery loop the other four modalities open.
20–30 min sessions using full-leg or body compression garments. Completely passive — simply lie back as the pneumatic system cycles through sequential pressure patterns. Most clients fall asleep.
EBOO (Extracorporeal Blood Oxygenation and Ozonation) is the most advanced form of ozone therapy available. Blood is drawn from the body, treated with medical-grade ozone and ultraviolet irradiation, and returned — triggering immune activation, pathogen elimination, mitochondrial restoration, and systemic anti-inflammatory response.
SONA operates all three clinical EBOO systems. Your protocol is selected at intake based on your health history, condition severity, and therapeutic goals. The dose formula: Gamma concentration × gas volume = ozone dose in micrograms (e.g. 40γ × 100mL = 4,000mcg).
60–200cc blood volume · 4,000–25,000 mcg ozone
The foundational EBOO protocol. A small volume of blood (60–200cc) is drawn, ozonated at doses of 4,000–25,000mcg, UV-irradiated via a cuvette, and reinfused. This is the entry-level clinical system and the most appropriate starting point for most patients. Requires 30–45 sessions to achieve optimal outcomes in major medical conditions. Tubing/cuvette set sourced from besttubing.com at $32.79 per treatment.
320–530cc blood volume · 70,000–122,000 mcg ozone · Dual UV pass
A significantly higher-volume blood treatment using a pump system for precise collection and delivery. Blood is UV-irradiated twice — once on collection and again on return. Requires only a single vein access point (22g minimum, 20g preferred). At 70,000–122,000mcg of ozone, this system delivers dramatically greater oxidative therapeutic effect per session than Tier 01. Tubing/cuvette/collection bag from besttubing.com at $58.79 per treatment.
2–3.5L blood volume · 150,000–300,000 mcg ozone · Dialysis-grade filtration
The EBOO Quantum is considered by ozone experts to be the premier ozone and UV blood irradiation device for any condition. Visually similar to dialysis but fundamentally different in mechanism and purpose — it treats 2 to 3.5 liters of blood with ozone doses of 150,000–300,000mcg per session. The tubing, cuvette, filter, and waste canister kit is $109 per treatment (sourced from besttubing.com). This is the most powerful extracorporeal blood therapy available outside a hospital setting.
The studies referenced below are presented for educational purposes only and do not constitute medical claims or endorsements. Research findings are population-level observations. Individual results vary. SONA Wellness services are supportive wellness modalities and are not intended to diagnose, treat, cure, or prevent any disease. Read full disclaimer →
Red and near-infrared light activates cytochrome c oxidase in the mitochondrial electron transport chain, measurably increasing ATP synthesis and modulating reactive oxygen species and nitric oxide signalling.
Photobiomodulation (PBM) at wavelengths of 600–1100nm is absorbed by cytochrome c oxidase (CcO), Complex IV of the mitochondrial respiratory chain. This interaction increases the electrochemical proton gradient, elevates mitochondrial membrane potential, and drives greater ATP synthesis through oxidative phosphorylation. Published research shows PBM also enhances phagocytic activity, modulates cytokine production, and supports lymphocyte proliferation. A 2022 umbrella review of 32 countries covering 204 randomised controlled trials found measurable clinical benefits across pain, inflammation, and tissue repair outcomes.
Published research in the International Journal of Artificial Organs documents EBOO as a scalable extracorporeal method capable of processing significantly larger blood volumes than autohemotherapy, with no recorded side effects across controlled clinical trials.
EBOO was developed and studied by Di Paolo, Bocci et al. beginning in 1990. A 2005 controlled trial in patients with peripheral artery disease (PAD) — 28 patients randomised to EBOO or intravenous prostacyclin — found that the EBOO group showed highly significant regression of skin lesions, reduced pain, and improved well-being. No side effects or complications were recorded across 210 EBOO treatments. Separately, a 2022 analysis published in PMC calculated that ozone dialysis (EBOO) delivers 32–46× more ozone in micrograms than conventional gravity major autohemotherapy. A session treating 4,800mL of blood with ozone/oxygen yields 4–5× elevated thiobarbituric acid reactants — a measure of oxidative signalling — without erythrocyte haemolysis.
Far-infrared saunas produce wavelengths (4–14μm) that resonate with water molecules in tissue, penetrating 4–5cm below the skin surface and triggering measurable cardiovascular, heat shock protein, and detoxification responses.
Far-infrared (FIR) radiation penetrates significantly deeper than conventional convective heat. At therapeutic temperatures, sustained core hyperthermia activates HSP70 and HSP90 heat shock proteins — molecular chaperones involved in protein homeostasis and cellular repair. Cardiovascular studies note heart rate and cardiac output responses comparable to moderate aerobic exercise. Published sweat analyses document elevated concentrations of heavy metals and environmental compounds in FIR-induced sweat compared to baseline. A review in Canadian Family Physician (2009) summarised FIR sauna evidence for cardiovascular risk factor reduction, including blood pressure and endothelial function.
Every modality at SONA has a documented physiological mechanism published in peer-reviewed literature. The following are foundational studies from indexed journals that inform our approach. These citations are provided for education — not as medical claims.
Background: Since 1990, the research group led by Di Paolo and Bocci developed an extracorporeal circulation method for blood ozonation — EBOO — with the aim of amplifying results seen with standard ozone autohemotherapy.
Objective: To verify whether EBOO improves the skin lesions typical of peripheral artery disease (PAD) patients.
Methods: Twenty-eight patients with PAD were randomised to receive either EBOO or intravenous prostacyclin in a controlled clinical trial. Primary efficacy parameters included regression of skin lesions and pain, quality of life, and vascularisation.
Results: Patients treated with EBOO showed highly significant regression of skin lesions compared to the prostacyclin group. Additional parameters significantly different between groups included pain, pruritus, heavy legs, and overall well-being. No significant differences in lower limb vascularisation were found — suggesting the mechanism of EBOO action extends beyond direct arterial effects.
Safety: No side effects or complications were recorded across 210 EBOO treatment sessions.
⚠ Cited for educational context only. This study does not constitute a medical claim. Consult a qualified physician before beginning any treatment. Full disclaimer →
Background: Ozone has been used in autohemotherapy (AHT) for four decades with encouraging results, but clinical application has been largely insufficient due to the limited blood volume treatable with AHT (approximately 250mL). EBOO was developed to address this limitation via high-efficiency extracorporeal circulation.
Method: The EBOO apparatus treats with oxygen-ozone mixture (0.5–1 μg/mL oxygen) in one hour of extracorporeal circulation. Over 1,200 treatments were performed in 82 patients in both sheep and human validation studies. The standard therapeutic cycle: 7 weeks, 14 sessions of 1 hour each. Up to 4,800mL of heparinised blood treated per session.
Key Findings: A single EBOO session produced 4–5 fold elevated levels of thiobarbituric acid reactants — a marker of controlled oxidative signalling — with a proportional decrease in plasma protein thiols. No appreciable erythrocyte haemolysis was observed. No significant changes in routine blood chemistry were found at up to 60-day follow-up after the 14-session cycle.
Safety: Extracorporeal circulation was technically successful in 85% of cases using cubital veins. No technical problems reported. The technique is adaptable for concurrent use during haemodialysis.
⚠ Cited for educational context only. Not a medical claim or treatment recommendation.
Background: Multiple ozone delivery methods exist for blood treatment — direct intravenous injection (DIV), major autohemotherapy (MAH), hyperbaric ozone, and extracorporeal blood oxygenation and ozonation (EBOO, also called ozone dialysis). These methods have not been systematically compared for actual ozone dose delivered in micrograms.
Analysis: The authors calculated delivered ozone doses (μg) for each method at commonly used clinical concentrations. Gravity MAH treats 200mL of blood with 200mL of ozone gas; at 50 μg/mL that delivers 10,000 μg total. At maximum concentration of 70 μg/mL, 14,000 μg is delivered. By contrast, extracorporeal EBOO / ozone dialysis treats the entire circulatory blood volume through a semi-permeable dialysis membrane with continuous ozone gas flow.
Key Finding: Ozone dialysis delivers, on average, at least 3× more ozone than other high-dose delivery methods — and in some configurations up to 32–46× more than gravity MAH. The authors conclude that ozone dialysis differs fundamentally from other blood ozone delivery methods and represents a distinct category of treatment intensity.
Safety: Extracorporeal EBOO has been performed for at least two decades with no published reports of injuries in the medical literature.
⚠ Cited for educational context only. Ozone therapy is not FDA-approved as a medical treatment.
Background: Low-level light therapy (LLLT) has emerged as a significant addition to light-based therapeutic interventions. The field is highly commercialised, with devices marketed directly to consumers, creating a tension between the commercial and clinical sectors that complicates evidence assessment.
Mechanism: The absorption of red and near-infrared light energy — photobiomodulation — enhances mitochondrial ATP production by activating cytochrome c oxidase (CcO), Complex IV of the mitochondrial respiratory chain. This interaction increases the electrochemical proton gradient, elevates membrane potential, and drives greater oxidative phosphorylation. Downstream effects include enhanced cell signalling, growth factor synthesis, and attenuation of oxidative stress.
Clinical Review: The author summarises the clinical evidence base for photobiomodulation across tissue repair, pain, inflammation, and aesthetic applications. Key therapeutic wavelengths fall within 600–1100nm — the optical window in which light penetrates tissue without significant absorption by water or haemoglobin.
Regulatory Context: The review discusses the regulatory framework governing PBM devices and highlights the challenge of establishing reproducible, scientifically measurable outcomes given the wide variability in device output, dosing parameters, and treatment protocols across commercially available systems.
⚠ Cited for educational context only. Not a medical claim. Individual responses to photobiomodulation vary.
Background: Photobiomodulation is a non-invasive therapy increasingly used for pain, inflammation, and tissue repair, yet a comprehensive synthesis of its effectiveness across multiple health outcomes has been lacking. This umbrella review addresses that gap.
Methods: The authors conducted an umbrella review of meta-analyses of randomised controlled trials (RCTs), searching five major databases up to December 2023. Two independent reviewers assessed methodological quality using AMSTAR 2 and evaluated certainty of evidence using a modified GRADE framework. Pooled effect sizes were recalculated as standardised mean differences with 95% confidence intervals. The study is registered with PROSPERO (CRD42023495502).
Scope: 204 original articles from 32 countries across six continents were included, all published between 2019–2023. Applications reviewed include pain conditions (fibromyalgia, osteoarthritis, tendinopathy), inflammatory disorders, wound healing, cognitive function, neurological outcomes, and oncology supportive care.
Key Findings: PBM demonstrated measurable clinical benefits across multiple outcomes with varying levels of evidence certainty. The immunomodulatory effects of PBM include enhanced phagocytic activity, modulated cytokine production, and lymphocyte proliferation support. The authors highlight photobiomodulation's biphasic dose-response — low doses reduce ROS in oxidative-stressed cells, while moderate doses stimulate cellular proliferation and antioxidant defences.
⚠ Cited for educational context only. Umbrella reviews reflect population-level data; individual results vary significantly.
Background: Far-infrared (FIR) saunas differ fundamentally from conventional saunas in that they produce radiant heat at wavelengths (4–14μm) that resonate with water molecules and organic tissue, penetrating 4–5cm below the skin surface rather than heating the ambient air. This penetration depth enables a greater elevation of core body temperature at lower ambient temperatures, which is better tolerated by many patients — including those with cardiovascular vulnerability.
Cardiovascular Effects: The author reviews published evidence on FIR sauna use in the context of cardiovascular risk factors including hypertension, congestive heart failure, and endothelial dysfunction. Repeated FIR sauna sessions have been shown to improve endothelium-dependent vasodilation, normalise autonomic nervous system activity, and reduce systemic blood pressure in hypertensive patients.
Exercise Equivalence: Cardiovascular responses during FIR sauna sessions — including heart rate elevation and cardiac output increase — are comparable in intensity to moderate aerobic exercise, suggesting therapeutic value for patients who cannot engage in conventional physical activity.
Heat Shock Proteins: Sustained hyperthermia activates HSP70 and HSP90 family heat shock proteins — molecular chaperones involved in protein homeostasis and cellular repair cascades — providing cellular-level regenerative benefit alongside the cardiovascular effects.
⚠ Cited for educational context only. FIR sauna is a wellness modality and not a treatment for cardiovascular disease.
Each modality is powerful alone. In the right sequence, they form a regenerative cycle that compounds across every session.
Build Your Protocol →Begin with Hydro Colonic Therapy to clear the gut — the primary site of toxin accumulation.
The gut is the entry point for 70% of the immune system and the primary route of toxin accumulation. Without clearing this pathway first, downstream protocols must work against an already-burdened system. Clearing the gut first amplifies the effectiveness of every modality that follows.
EBOO restores oxygen delivery and eliminates blood-borne burden — carrying therapeutic oxygen unimpeded.
With the gut clear, the bloodstream is no longer re-absorbing gut-derived toxins. EBOO now supercharges oxygen delivery to tissues that have been chronically under-oxygenated. The immune activation from ozone primes every cell for the cellular activation that follows.
Red Light via the Trifecta drives whole-body mitochondrial energy production.
Cells primed with oxygen from EBOO now receive photonic energy to drive the electron transport chain directly. ATP output is maximized. Cells that were oxygen-depleted and photon-deficient are now operating at peak metabolic capacity — ready to repair, regenerate, and detox at depth.
Infrared Sauna raises core temperature, mobilizing stored toxins through sweat.
With circulation amplified by EBOO and cellular energy high from red light, the infrared sauna now mobilizes fat-soluble toxins stored in adipose tissue. The cardiovascular benefit of the sauna compounds the circulatory improvements, and the deep sweating provides a primary elimination route for mobilized compounds.
Compression drives lymphatic clearance — so the next session starts from a higher baseline.
The lymphatic system has no pump of its own — it relies on muscle movement and external compression. After the preceding four modalities have mobilized toxins, generated metabolic byproducts, and stimulated immune activity, compression therapy provides the mechanical force to sweep all of it out of the interstitial fluid and into elimination pathways.
Peer-reviewed clinical review — mechanisms, evidence, treatment protocols, and cost analysis vs. conventional vascular surgery.
Far-infrared heat therapy for cardiovascular health, chronic pain, exercise recovery — 9 level I & II studies reviewed.
An honest clinical review — applications, considerations, safety. Transparent about both reported benefits and evidence limitations.
Intermittent pneumatic compression for lymphatic support — 49 studies, 12 RCTs, with NIRFLI imaging evidence.
Full-body photobiomodulation — 4,700+ LEDs at 150 mW/cm². Supported by 4,000+ studies across 70+ countries. 12-minute sessions.
Each white paper includes peer-reviewed evidence, mechanism diagrams, treatment protocols, and cost analysis vs. traditional medical approaches.
© 2026 SONASONA is not a spa. It is a precision wellness facility designed around equipment that delivers measurable physiological change — in a space as intentional as the protocols inside it.
Every room, every protocol, every interaction exists to deepen the result.
SONA Wellness
[Studio Address]
[City, State ZIP]
[Phone Number]
[Email Address]
[Parking and access details for your studio]
Your first session begins with an intake assessment. We build the protocol around you.